Dr. Bashar H. Bargoty, MD
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 309
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
TN license 52587 -
Critical Care Medicine (Internal Medicine) Physician
TN license 52587
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Parkwest Medical Center Knoxville, TN
- Fort Sanders Regional Medical Center Knoxville, TN
- Methodist Medical Center of Oak Ridge Oak Ridge, TN
- Cumberland Medical Center Crossville, TN
- Morristown Hamblen Hospital Association Morristown, TN
Medical groups
- Statcare Inpatient LLC (109 clinicians)
- Methodist Medical Center (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 309
- Services billed
- 1,653
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 246 | 112 |
| Critical care, first 30-74 minutes | 173 | 76 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 99 | 55 |
| Established patient office or other outpatient visit, 30-39 minutes | 80 | 64 |
| Test to examine how well the lungs exchange gases | 74 | 70 |
| Test to determine lung volumes using gas dilution or washout | 73 | 69 |
| Test to measure expiratory airflow and volume | 71 | 65 |
| X-ray of chest, 2 views | 41 | 39 |
| New patient office or other outpatient visit, 45-59 minutes | 34 | 34 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 31 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Knoxville, TN | 211 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Knoxville, TN | 202 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Knoxville, TN | 192 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Knoxville, TN | 95 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Knoxville, TN | 83 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Knoxville, TN | 55 |
| Prednisone Other prescribers in Knoxville, TN | 49 |
| Pantoprazole Sodium Other prescribers in Knoxville, TN | 38 |
| Montelukast Sodium Other prescribers in Knoxville, TN | 28 |
| Methylprednisolone Other prescribers in Knoxville, TN | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 38 payments worth $1,194 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $321 |
|---|---|
| Abbott Laboratories | $146 |
| Regeneron Healthcare Solutions, Inc. | $117 |
| Galvanize Therapeutics, Inc | $116 |
| GlaxoSmithKline, LLC. | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.77 |
| Baxter Healthcare | $50.14 |
| Grifols USA, LLC | $48.74 |
| Food and Beverage | $1,194 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $21,125 in research payments for these studies, mostly to the institutions running them.
- A randomized, double-blind, placebo-controlled, parallel-group, multic
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.